LYTIX BIOPHARMA ASA logo LYTIX BIOPHARMA ASA

📰 Media 🎯 Kursmål 📦 Blokksalg 🚩 Flagging 👥 Eiere

Selskapsinformasjon

Ticker: LYTIX
Børsverdi: 615 MNOK
Nordnet 785
Avanza 49
Kommende hendelserHendelser ℹ️
Rapport: 13.11.2026
09.11.2026 07:00

Lytix Biopharma to Present NeoLIPA Phase II Results in Late-Breaking Oral Presentation at ESMO IO 2026

Oslo, Norway, November 9, 2026 - Lytix Biopharma ASA ("Lytix"), a clinical-stage oncology company developing novel intratumoral cancer therapies, today announced that its late-breaking abstract presenting updated results from the Phase II NeoLIPA trial has been accepted for oral presentation in a Pr...

Les hele pressemeldingen

Antall Eiere